[시장보고서]eClinical 솔루션 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 제공 형태별, 개발 단계별, 최종 용도별, 지역별, 부문 예측(2026-2033년)

eClinical 솔루션 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 제공 형태별, 개발 단계별, 최종 용도별, 지역별, 부문 예측(2026-2033년)

eClinical Solutions Market Size, Share & Trends Analysis Report By Product (eCOA, CTMS, EDC & CDMS), By Delivery Mode (Cloud and Web-Based, On- Premise), By Development Phase, By End Use, By Region, And Segment Forecasts, 2026 - 2033

상품코드 : 1941505

리서치사 : Grand View Research

발행일 : 2026년 01월

페이지 정보 : 영문 100 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,981,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,491,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 13,510,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

eClinical 솔루션 시장 개요

세계의 eClinical 솔루션 시장 규모는 2025년 115억 3,000만 달러로 추정되며, 2033년에 350억 8,000만 달러에 이를 것으로 예측됩니다.

또한 2026-2033년 연평균 15.07% 성장할 것으로 예측됩니다. 바이오의약품 및 제약기업의 연구개발 활동 증가는 시장 성장을 가속하는 주요 트렌드 중 하나입니다.

또한, 임상 검사 분야의 소프트웨어 솔루션 도입 확대가 시장 성장을 견인할 것으로 예측됩니다. 주요 제약사 및 생명공학 기업의 임상시험 아웃소싱 및 아웃소싱 증가는 예측 기간 동안 전례 없는 속도로 시장을 주도할 것으로 예측됩니다.

주요 제약 및 생명공학 기업들의 임상시험 아웃소싱 및 아웃소싱 증가는 예측 기간 동안 전례 없는 속도로 시장을 견인하는 요인이 될 것으로 예측됩니다. 의약품 개발은 임상 데이터 관리, 전자 데이터 수집, 데이터 변환 및 표준화, 통계 프로그래밍, 데이터 보고 역량을 강화하는 것이 매우 중요합니다. 주요 제약사들이 이러한 서비스를 이용하는 경향이 높아지는 배경에는 내부 직원에 대한 수요 감소, 비용 효율성 향상, 자원의 효율적 관리, 임상 검사에서 유익하고 편향되지 않은 결과 도출 등의 직접적인 요인이 작용한 것으로 추정되며, 이는 성장의 폭을 더욱 넓혀주고 있습니다.

임상 검사의 분산화는 임상 검사의 수를 크게 증가시킵니다. Tufts CSDD가 바이오제약 기업 및 CRO(임상시험수탁기관)와 공동으로 실시한 2022년 7월 조사에서는 분산형 임상검사(DCT)와 하이브리드 검사 모델이 스폰서와 CRO의 협력에 미치는 영향을 검증했습니다. 이번 조사에 따르면, 2020-2022년 사이에 DCT 요소를 도입한 세계 의약품 검사가 눈에 띄게 증가하고 있으며, 향후 몇 년 동안 더 큰 성장이 예상된다고 밝혔습니다. DCT 도입의 주요 과제로는 데이터 표준 및 규제 불일치, 데이터 프라이버시 문제, 건강 앱 및 웨어러블 기기에 대한 기술적 검증 요건 등을 꼽을 수 있습니다.

또한, 규제 준수 및 데이터 보안 요구 사항은 eClinical 솔루션 시장의 성장을 이끄는 주요 요인입니다. 임상검사에서는 대량의 기밀성이 높은 환자 데이터와 검사 데이터가 생성되기 때문에 FDA 21 CFR Part 11, GDPR(EU 개인정보보호규정), HIPAA, ICH-GCP 등의 규정 준수가 필수적입니다. 스폰서 및 CRO는 감사 추적, 전자 서명, 역할 기반 액세스 제어를 유지하면서 안전한 데이터 수집, 저장 및 전송을 보장하기 위해 고급 eClinical 플랫폼에 대한 의존도를 높이고 있습니다. 여러 국가에 걸친 임상 검사의 복잡성이 증가하고 규제 당국의 모니터링이 강화됨에 따라, 클라우드 기반의 검증된 컴플라이언스 대응 솔루션 도입이 가속화되고 있습니다. eClinical 기술은 강력한 컴플라이언스 프레임워크와 데이터 보호 메커니즘을 제공하여 규제 리스크를 줄이고, 검사의 무결성을 높이며, 이해관계자의 신뢰를 구축하고, 시장 성장을 가속합니다.

고급 데이터 분석 및 AI 지원 임상 데이터 플랫폼에 대한 수요가 증가하고 있으며, 연구 생산성을 가속화하고 임상 개발 주기를 단축하기 위해 노력하고 있습니다. 예를 들어, 2025년 2월 생명과학 기업들은 임상시험의 복잡성 증가, 다양한 소스로부터의 데이터 양 증가, 의약품 개발 시 의사결정을 위한 신속한 지식의 필요성 등의 문제가 심각해지고 있는 것으로 보고되고 있습니다.

주요 시장 진출기업들 역시 제공 범위 확대와 수요 증가에 대한 대응에 적극적으로 나서고 있습니다. 예를 들어, eClinical Solutions는 주력 제품인 elLuminate Clinical Data Cloud 플랫폼에 자연어 쿼리 지원(elLuminate Assist), 자동 데이터 분류, 머신러닝을 통한 감사 추적 검토 등 AI 및 머신러닝 기능을 탑재하여 이러한 수요에 대응하고 있습니다. 머신러닝을 통한 감사추적 검토 등의 AI 및 머신러닝 기능을 탑재하여 이러한 수요에 대응하고 있습니다. 이러한 혁신을 통해 고객은 일상 업무를 자동화하고, 데이터 워크플로우를 최적화하며, 복잡한 데이터 세트를 효율적으로 해석할 수 있습니다. 제약사 및 CRO(임상시험수탁기관)가 검사 기간 단축 및 업무 효율성 향상을 위해 이러한 기능의 중요성이 점점 더 커지고 있습니다. 2024-2025년에 걸쳐 CRO 3곳을 포함한 20개의 신규 고객을 확보했으며, 특히 임상시험의 사이클 타임 문제를 해결하기 위해 기술 제품군을 확장했습니다. 이는 데이터 인텔리전스와 AI 통합이 회사의 사업 성장을 이끄는 주요 요소임을 보여줍니다.

영문목차

eClinical Solutions Market Summary

The global eClinical solutions market size was estimated at USD 11.53 billion in 2025 and is projected to reach USD 35.08 billion by 2033, growing at a CAGR of 15.07% from 2026 to 2033. Increasing research and development activities by biopharma and pharma companies is one of the key trends boosting market growth.

Moreover, the growing incorporation of software solutions in clinical trials is projected to lead the market growth. The increasing outsourcing and externalization of clinical trials by the majority of the prominent pharmaceutical and biotechnological companies is presumed to be responsible for driving the market at an unprecedented rate throughout the forecast period.

The increasing outsourcing and externalization of clinical trials by the majority of the prominent pharmaceutical and biotechnological companies is presumed to be responsible for driving the market at an unprecedented rate throughout the forecast period. Drug development is of utmost importance as it enhances the capabilities in clinical data management, electronic data capture, data conversion, and standardization, as well as statistical programming and data reporting. The rising inclination of major pharmaceutical companies toward these services is also presumed to be a direct consequence of reduced demand for internal staff, enhanced cost-efficiency, efficient management of resources, and production of lucrative & unbiased results in clinical trials, which further widens the scope of growth.

The decentralization of clinical trials significantly increases the number of clinical trials. A July 2022 study by the Tufts CSDD, conducted in collaboration with biopharmaceutical companies and contract research organizations (CROs), examined the impact of decentralized clinical trials (DCTs) and hybrid trial models on sponsor-CRO collaborations. The research highlighted a notable increase in global drug trials incorporating DCT components between 2020 and 2022, with expectations for further growth in the years to come. Key challenges to implementing DCTs include inconsistencies in data standards and regulations, data privacy concerns, and technical validation requirements for health apps and wearable devices.

Furthermore, regulatory compliance and data security requirements are key drivers of growth in the eClinical solutions market. Clinical trials generate large volumes of sensitive patient and trial data, making adherence to regulations such as FDA 21 CFR Part 11, GDPR, HIPAA, and ICH-GCP essential. Sponsors and CROs increasingly rely on advanced eClinical platforms to ensure secure data capture, storage, and transfer, while maintaining audit trails, electronic signatures, and role-based access controls. The growing complexity of multi-country trials, coupled with stricter oversight by regulatory authorities, has accelerated the adoption of cloud-based, validated, and compliant solutions. By providing robust compliance frameworks and data protection mechanisms, eClinical technologies reduce regulatory risk, enhance trial integrity, and build stakeholder confidence, thereby fueling market growth..

The increasing demand for advanced data analytics and AI enabled clinical data platforms to accelerate research productivity and reduce clinical development cycle times. For instance, in February 2025, life sciences organizations reportedly faced escalating trial complexity, larger volumes of data from diverse sources, and the need for faster insights to make informed decisions during drug development.

Notable market players are also taking initiative to expand their offering and responding to the growing demand. For instance, eClinical Solutions has responded to this demand by enhancing its flagship elluminate Clinical Data Cloud platform with embedded AI and machine learning capabilities, such as natural language query support (elluminate Assist), automated data classification, and machine learning driven audit trail reviews. These innovations help clients automate routine tasks, optimize data workflows, and interpret complex datasets more efficiently,capabilities that are increasingly critical as pharmaceutical sponsors and contract research organizations (CROs) seek to shorten trial timelines and improve operational efficiency. In 2024-2025, the company added 20 net new clients, including three CROs, and it expanded its technology suite specifically to address cycle time challenges in clinical trials, which underlines how data intelligence and AI integration are key drivers of its business growth.

Global eClinical Solutions Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global eClinical solutions market report on the basis of product, delivery mode, development phase, end use, and region:

Product Outlook (Revenue, USD Million, 2021 - 2033)
Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS)
- Traditional
- AI-Enhanced
Clinical Trial Management Systems (CTMS)
- Traditional
- AI-Enhanced
Clinical Analytics Platforms
- Traditional
- AI-Enhanced
Randomization and Trial Supply Management (RTSM)
- Traditional
- AI-Enhanced
Clinical Data Integration Platforms
- Traditional
- AI-Enhanced
Electronic Clinical Outcome Assessment (eCOA)
- Traditional
- AI-Enhanced
Safety Solutions
- Traditional
- AI-Enhanced
Electronic Trial Master File (eTMF)
- Traditional
- AI-Enhanced
Econsent
- Traditional
- AI-Enhanced
Delivery Mode Outlook (Revenue, USD Million, 2021 - 2033)
Cloud and Web-Based
On-Premise
Development Phase Outlook (Revenue, USD Million, 2021 - 2033)
Phase I
Phase II
Phase III
Phase IV
End Use Outlook (Revenue, USD Million, 2021 - 2033)
Hospitals/Healthcare providers
CROs
Academic Institutes
Pharma & Biotech Organizations
Medical Device Manufacturers
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Netherlands
- Sweden
- Denmark
Asia Pacific
- Japan
- China
- India
- South Korea
- Australia
- New Zealand
- Taiwan
- Hong Kong
- Singapore
- Thailand
- Vietnam
Latin America
- Brazil
- Argentina
- Chile
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Egypt
- Qatar

Chapter 1 eClinical Solutions Market: Research Methodology & Scope

1.1 Market Segmentation & Scope
- 1.1.1 eClinical Solutions Market Segment Scope
- 1.1.2 Regional Scope
- 1.1.3 Estimates & Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
- 1.3.1 Purchased database:
- 1.3.2 GVR's Internal Database
- 1.3.3 Secondary sources
- 1.3.4 Primary Research:
- 1.3.5 Details of Primary Research
  - 1.3.5.1 Region-specific eClinical solutions market data for primary interviews
    - 1.3.5.1.1 North America
    - 1.3.5.1.2 Europe
    - 1.3.5.1.3 Asia Pacific
    - 1.3.5.1.4 Latin America
    - 1.3.5.1.5 Middle East and Africa
1.4 Information or Data Analysis
- 1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
- 1.6.1 eClinical solutions market
  - 1.6.1.1 Consensus-based Estimates & forecasting
    - 1.6.1.1.1 eClinical solutions market - Commodity Flow Analysis
      - 1.6.1.1.1.1 Commodity Flow Analysis level: eConsent in the healthcare market
      - 1.6.1.1.1.2 Country-level assumptions
  - 1.6.1.2 Sub-segment level assumptions
  - 1.6.1.3 Total addressable market analysis (Model 2)
- 1.6.2 Pharma HUB and patient access support service market
  - 1.6.2.1 Pharma HUB and patient access support service market: Commodity Flow Analysis
1.7 List of Secondary Sources
1.8 Abbreviations
1.9 Objectives
- 1.9.1 Objective 1
- 1.9.2 Objective 2
- 1.9.3 Objective 3
1.10 Market Definitions

Chapter 2 eClinical Solutions Market: Executive Summary

2.1 Market Outlook
2.2 Segment Outlook
- 2.2.1 Product Segment Outlook
- 2.2.2 Development Phases & Delivery Mode Segment Outlook
- 2.2.3 End use Segment Outlook
- 2.2.4 Competitive outlook

Chapter 3 eClinical Solutions Market: Variables Trends & Scope

3.1 Ancillary Market Analysis
- 3.1.1 eConsent Market
- 3.1.2 Electronic Clinical Outcome Assessment Solutions Market
- 3.1.3 Clinical Trials Management System Market
3.2 Pricing Analysis
- 3.2.1 By product
  - 3.2.1.1 eCOA
  - 3.2.1.2 EDC & CDMS
  - 3.2.1.3 Clinical Analytics Platforms
  - 3.2.1.4 Clinical data integration platforms
  - 3.2.1.5 Safety solutions
  - 3.2.1.6 CTMS
  - 3.2.1.7 RTSM
  - 3.2.1.8 eTMF
- 3.2.2 By delivery mode
- 3.2.3 By development phase
3.3 User/Buyer Perception Analysis
- 3.3.1 Market influencer analysis
  - 3.3.1.1 Regulatory Requirements
  - 3.3.1.2 Technological Developments
  - 3.3.1.3 Product Differentiation
  - 3.3.1.4 Demand from Consumers
3.4 Technology Overview
- 3.4.1 eClinical solutions changing technology & adoption
3.5 Regulatory Overview
- 3.5.1 Regulatory Landscape
  - 3.5.1.1 List of regulations, by country
3.6 Market Dynamics
- 3.6.1 Market Driver Analysis
  - 3.6.1.1 Increasing externalization of clinical trial studies by large pharmaceutical and biopharmaceutical companies
  - 3.6.1.2 Advantages of eClinical solutions
  - 3.6.1.3 Presence of strong range of products in pipeline
  - 3.6.1.4 Increased adoption of eConsent in clinical trials
    - 3.6.1.4.1 eConsent is becoming increasingly accepted and adopted in various industries, particularly in healthcare and clinical trials.
    - 3.6.1.4.2 Advancements in mobile technologies are poised to revolutionize the processes of designing, delivering, and managing informed consent
    - 3.6.1.4.3 The implementation of eConsent in clinical trials has shown to improve patient comprehension and consequently create better trial subjects.
    - 3.6.1.4.4 The implementation of eConsent is beneficial for clinical trial sites, as it greatly improves the consent process.
    - 3.6.1.4.5 Elderly participants report high satisfaction with eConsent
    - 3.6.1.4.6 econsent enhances version control, remote monitoring, and document management.
  - 3.6.1.5 Increased strategic acquisitions and partnerships deals
  - 3.6.1.6 Integration of econsent with other eclinical solutions
  - 3.6.1.7 Market Drivers - Key Insights from Signant Health Survey
- 3.6.2 Market Restraints Analysis
  - 3.6.2.1 Scarcity of skilled research professionals
  - 3.6.2.2 Lack of recognition
  - 3.6.2.3 Authority concerns and its related solutions
    - 3.6.2.3.1 Protection of patient data
    - 3.6.2.3.2 Sharing electronic consent data
    - 3.6.2.3.3 Regional and local data privacy laws
    - 3.6.2.3.4 Site burden
    - 3.6.2.3.5 Trial participant verification
    - 3.6.2.3.6 Responsibilities of the Investigator as the Process Owner of the Informed Consent Process
- 3.6.3 Market Challenge Analysis
  - 3.6.3.1 Market-related barriers
    - 3.6.3.1.1 Lack of education and communication
    - 3.6.3.1.2 Lack of lean processes and operations
  - 3.6.3.2 Market Challenges - Key Insights from Signant Health Survey
3.7 Industry Analysis - Porter's
3.8 eClinical Solutions Market - SWOT Analysis, by Factor (Political & Legal, Economic, Social and Technological)
3.9 COVID-19 Impact Analysis
- 3.9.1 Case Study - eConsent implementation during COVid -19 pandemic
- 3.9.2 Developments & Strategic Outcomes
- 3.9.3 Strategies implemented by companies
  - 3.9.3.1 Oracle
  - 3.9.3.2 Calyx
  - 3.9.3.3 Datatrak International, Inc.
  - 3.9.3.4 Medidata Solution, Inc.
  - 3.9.3.5 IBM
  - 3.9.3.6 eClinical Solutions
  - 3.9.3.7 Veeva Systems
  - 3.9.3.8 Elsevier
  - 3.9.3.9 IQVIA
  - 3.9.3.10 Pharmaceutical Product Development (PPD)
  - 3.9.3.11 ICON, plc
  - 3.9.3.12 PRA Health Sciences

Chapter 4 eClinical Solutions Market: Product Analysis

4.1 Product Business Analysis
- 4.1.1 Electronic data capture (EDC) & clinical data management systems (CDMS)
  - 4.1.1.1 EDC & CDMS market estimates and forecasts, 2021 - 2033 (USD Million)
    - 4.1.1.1.1 Traditional market estimates and forecasts, 2021 - 2033 (USD Million)
    - 4.1.1.1.2 AI-Enhanced market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.1.2 Clinical trial management systems (CTMS)
  - 4.1.2.1 Clinical trial management systems (CTMS) market estimates and forecasts, 2021 - 2033 (USD Million)
    - 4.1.2.1.1 Traditional market estimates and forecasts, 2021 - 2033 (USD Million)
    - 4.1.2.1.2 AI-Enhanced market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.1.3 Clinical analytics platform
  - 4.1.3.1 Clinical analytics platform market estimates and forecasts, 2021 - 2033 (USD Million)
    - 4.1.3.1.1 Traditional market estimates and forecasts, 2021 - 2033 (USD Million)
    - 4.1.3.1.2 AI-Enhanced market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.1.4 Electronic clinical outcome assessment (ECOA)
  - 4.1.4.1 Electronic clinical outcome assessment (ECOA) market estimates and forecasts, 2021 - 2033 (USD Million)
    - 4.1.4.1.1 Traditional market estimates and forecasts, 2021 - 2033 (USD Million)
    - 4.1.4.1.2 AI-Enhanced market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.1.5 Clinical data integration platform
  - 4.1.5.1 Clinical data integration platform market estimates and forecasts, 2021 - 2033 (USD Million)
    - 4.1.5.1.1 Traditional market estimates and forecasts, 2021 - 2033 (USD Million)
    - 4.1.5.1.2 AI-Enhanced market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.1.6 Safety solutions
  - 4.1.6.1 Safety solutions market estimates and forecasts, 2021 - 2033 (USD Million)
    - 4.1.6.1.1 Traditional market estimates and forecasts, 2021 - 2033 (USD Million)
    - 4.1.6.1.2 AI-Enhanced market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.1.7 Randomization and trial supply management (RTSM)
  - 4.1.7.1 RTSM market estimates and forecasts, 2021 - 2033 (USD Million)
  - 4.1.7.1 1 Traditional market estimates and forecasts, 2021 - 2033 (USD Million)
    - 4.1.7.1.2 AI-Enhanced market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.1.8 Electronic Trial Master File (eTMF)
  - 4.1.8.1 eTMF market estimates and forecasts, 2021 - 2033 (USD Million)
    - 4.1.8.1.1 Traditional market estimates and forecasts, 2021 - 2033 (USD Million)
    - 4.1.8.1.2 AI-Enhanced market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.1.9 eConsent
  - 4.1.9.1 eConsent market estimates and forecasts, 2021 - 2033 (USD Million)
    - 4.1.9.1.1 Traditional market estimates and forecasts, 2021 - 2033 (USD Million)
    - 4.1.9.1.2 AI-Enhanced market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5 eClinical Solutions Market: Delivery Mode Analysis

5.1 Delivery Mode Business Analysis
- 5.1.1 Cloud- and Web-based
  - 5.1.1.1 Cloud and web-based market estimates and forecasts, 2021 - 2033 (USD Million)
- 5.1.2 On-Premise
  - 5.1.2.1 On-Premise market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6 eClinical Solutions Market: Development Phase Analysis

6.1 Development Phase Business Analysis
- 6.1.1 Phase I
  - 6.1.1.1 Phase I market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.1.2 Phase II
  - 6.1.2.1 Phase II market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.1.3 Phase III
  - 6.1.3.1 Phase III market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.1.4 Phase IV
  - 6.1.4.1 Phase IV market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7 eClinical Solutions Market: End Use Analysis

7.1 End Use Business Analysis
- 7.1.1 Hospitals/healthcare providers
  - 7.1.1.1 Hospitals market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.1.2 Contract Research Organizations (CROs)
  - 7.1.2.1 CROs market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.1.3 Academic institutes
  - 7.1.3.1 Academic institutes market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.1.4 Pharma & biotech organizations
  - 7.1.4.1 Pharma & biotech organizations market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.1.5 Medical device manufacturers
  - 7.1.5.1 Medical device manufacturers market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8 eClinical Solutions Market: Regional Market Analysis, By Product, By Delivery Mode, By Development Phase, and By End Use, 2021 - 2033 (USD Million)

8.1 Regional Market Share Analysis, 2025 & 2033
8.2 Regional Market Snapshot
8.3 North America
- 8.3.1 North America eClinical solutions market estimates and forecasts by countries, 2021 - 2033 (USD Million)
- 8.3.2 U.S.
  - 8.3.2.1 Key Country Dynamics
  - 8.3.2.2 Regulatory framework
  - 8.3.2.3 U.S. eClinical solutions market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.3.3 Canada
  - 8.3.3.1 Key Country Dynamics
  - 8.3.3.2 Regulatory framework
  - 8.3.3.3 Canada eClinical solutions market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.3.4 Mexico
  - 8.3.4.1 Key Country Dynamics
  - 8.3.4.2 Regulatory framework
  - 8.3.4.3 Mexico eClinical solutions market estimates and forecasts, 2021 - 2033 (USD Million)
8.4 Europe
- 8.4.1 Europe eClinical solutions market estimates and forecasts by countries, 2021 - 2033 (USD Million)
- 8.4.2 UK
  - 8.4.2.1 Key Country Dynamics
  - 8.4.2.2 Regulatory framework
  - 8.4.2.3 UK eClinical solutions market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.4.3 Germany
  - 8.4.3.1 Key Country Dynamics
  - 8.4.3.2 Regulatory framework
  - 8.4.3.3 Germany eClinical solutions market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.4.4 France
  - 8.4.4.1 Key Country Dynamics
  - 8.4.4.2 Regulatory framework
  - 8.4.4.3 France eClinical solutions market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.4.5 Italy
  - 8.4.5.1 Key Country Dynamics
  - 8.4.5.2 Regulatory framework
  - 8.4.5.3 Italy eClinical solutions market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.4.6 Spain
  - 8.4.6.1 Key Country Dynamics
  - 8.4.6.2 Regulatory framework
  - 8.4.6.3 Spain eClinical solutions market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.4.7 Netherlands
  - 8.4.7.1 Key Country Dynamics
  - 8.4.7.2 Regulatory framework
  - 8.4.7.3 Netherlands eClinical solutions market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.4.8 Denmark
  - 8.4.8.1 Key Country Dynamics
  - 8.4.8.2 Regulatory framework
  - 8.4.8.3 Denmark eClinical solutions market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.4.9 Sweden
  - 8.4.9.1 Key Country Dynamics
  - 8.4.9.2 Regulatory framework
  - 8.4.9.3 Sweden eClinical solutions market estimates and forecasts, 2021 - 2033 (USD Million)
8.5 Asia Pacific
- 8.5.1 Asia Pacific eClinical solutions market estimates and forecasts,2021 - 2033 (USD Million)
- 8.5.2 Japan
  - 8.5.2.1 Key Country Dynamics
  - 8.5.2.2 Regulatory framework
  - 8.5.2.3 Japan eClinical solutions market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.5.3 China
  - 8.5.3.1 Key Country Dynamics
  - 8.5.3.2 Regulatory framework
  - 8.5.3.3 China eClinical solutions market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.5.4 India
  - 8.5.4.1 Key Country Dynamics
  - 8.5.4.2 Regulatory framework
  - 8.5.4.3 India eClinical solutions market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.5.5 Australia
  - 8.5.5.1 Key Country Dynamics
  - 8.5.5.2 Regulatory framework
  - 8.5.5.3 Australia eClinical solutions market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.5.6 South Korea
  - 8.5.6.1 Key Country Dynamics
  - 8.5.6.2 Regulatory framework
  - 8.5.6.3 South Korea eClinical solutions market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.5.7 New Zealand
  - 8.5.7.1 Key Country Dynamics
  - 8.5.7.2 Regulatory framework
  - 8.5.7.3 New Zealand eClinical solutions market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.5.8 Taiwan
  - 8.5.8.1 Key Country Dynamics
  - 8.5.8.2 Regulatory framework
  - 8.5.8.3 Taiwan eClinical solutions market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.5.9 Hong Kong
  - 8.5.9.1 Key Country Dynamics
  - 8.5.9.2 Regulatory framework
  - 8.5.9.3 Hong Kong eClinical solutions market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.5.10 Singapore
  - 8.5.8.1 Key Country Dynamics
  - 8.5.8.2 Regulatory framework
  - 8.5.8.3 Singapore eClinical solutions market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.5.11 Thailand
  - 8.5.11.1 Key Country Dynamics
  - 8.5.11.2 Regulatory framework
  - 8.5.11.3 Thailand eClinical solutions market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.5.12 Vietnam
  - 8.5.12.1 Key Country Dynamics
  - 8.5.12.2 Regulatory framework
  - 8.5.12.3 Vietnam eClinical solutions market estimates and forecasts, 2021 - 2033 (USD Million)
8.6 Latin America
- 8.6.1 Latin America eClinical solutions market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.6.2 Brazil
  - 8.6.2.1 Key Country Dynamics
  - 8.6.2.2 Regulatory framework
  - 8.6.2.3 Brazil eClinical solutions market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.6.3 Argentina
  - 8.6.3.1 Key Country Dynamics
  - 8.6.3.2 Regulatory framework
  - 8.6.3.3 Argentina eClinical solutions market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.6.4 Chile
  - 8.6.4.1 Key Country Dynamics
  - 8.6.4.2 Regulatory framework
  - 8.6.4.3 Chile eClinical solutions market estimates and forecasts, 2021 - 2033 (USD Million)
8.7 Middle East and Africa
- 8.7.1 Middle East and Africa eClinical solutions market estimates and forecasts by countries, 2021 - 2033 (USD Million)
- 8.7.2 South Africa
  - 8.7.2.1 Key Country Dynamics
  - 8.7.2.2 Regulatory framework
  - 8.7.2.3 South Africa eClinical solutions market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.7.3 Saudi Arabia
  - 8.7.3.1 Key Country Dynamics
  - 8.7.3.2 Regulatory framework
  - 8.7.3.3 Saudi Arabia eClinical solutions market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.7.4 UAE
  - 8.7.4.1 Key Country Dynamics
  - 8.7.4.2 Regulatory framework
  - 8.7.4.3 UAE eClinical solutions market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.7.5 Qatar
  - 8.7.5.1 Key Country Dynamics
  - 8.7.5.2 Regulatory framework
  - 8.7.5.3 Qatar eClinical solutions market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.7.6 Egypt
  - 8.7.6.1 Key Country Dynamics
  - 8.7.6.2 Regulatory framework
  - 8.7.6.3 Egypt eClinical solutions market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9 eClinical Solutions Market: Competitive Landscape

9.1 Participant Overview
9.2 Company Market Position Analysis
9.3. Company Categorization
9.4. Strategy Mapping
9.5. Company Profiles/Listing
- 9.5.1. Datatrak International, Inc.
  - 9.5.1.1. Overview
  - 9.5.1.2. Financial performance
  - 9.5.1.3. Products & Services benchmarking
  - 9.5.1.4. Strategic initiatives
- 9.5.2. Oracle
  - 9.5.2.1. Overview
  - 9.5.2.2. Financial performance
  - 9.5.2.3. Products & Services benchmarking
  - 9.5.2.4. Strategic initiatives
- 9.5.3. Parexel International Corporation
  - 9.5.3.1. Overview
  - 9.5.3.2. Financial performance
  - 9.5.3.3. Products & Services benchmarking
  - 9.5.3.4. Strategic initiatives
- 9.5.4. Dassault Systemes
  - 9.5.4.1. Overview
  - 9.5.4.2. Financial performance
  - 9.5.4.3. Products & Services benchmarking
  - 9.5.4.4. Strategic initiatives
- 9.5.5. Bioclinica
  - 9.5.5.1. Overview
  - 9.5.5.2. Financial performance
  - 9.5.5.3. Products & Services benchmarking
  - 9.5.5.4. Strategic initiatives
- 9.5.6. CRF Health
  - 9.5.6.1. Overview
  - 9.5.6.2. Financial performance
  - 9.5.6.3. Products & Services benchmarking
  - 9.5.6.4. Strategic initiatives
- 9.5.7. ERT Clinical
  - 9.5.7.1. Overview
  - 9.5.7.2. Financial performance
  - 9.5.7.3. Products & Services benchmarking
  - 9.5.7.4. Strategic initiatives
- 9.5.8. eClinicalWorks
  - 9.5.8.1. Overview
  - 9.5.8.2. Financial performance
  - 9.5.8.3. Products & Services benchmarking
  - 9.5.8.4. Strategic initiatives
- 9.5.9. IBM Watson Health
  - 9.5.9.1. Overview
  - 9.5.9.2. Financial performance
  - 9.5.9.3. Products & Services benchmarking
  - 9.5.9.4. Strategic initiatives
- 9.5.10. Anju Life Sciences Software
  - 9.5.10.1. Overview
  - 9.5.10.2. Financial performance
  - 9.5.10.3. Products & Services benchmarking
  - 9.5.10.4. Strategic initiatives
- 9.5.11. eClinical Solutions
  - 9.5.11.1. Overview
  - 9.5.11.2. Financial performance
  - 9.5.11.3. Products & Services benchmarking
  - 9.5.11.4. Strategic initiatives
- 9.5.12. Maxisit
  - 9.5.12.1. Overview
  - 9.5.12.2. Financial performance
  - 9.5.12.3. Products & Services benchmarking
  - 9.5.12.4. Strategic initiatives
- 9.5.13. IQVIA
  - 9.5.13.1. Overview
  - 9.5.13.2. Financial performance
  - 9.5.13.3. Products & Services benchmarking
  - 9.5.13.4. Strategic initiatives
- 9.5.14. Castor
  - 9.5.14.1. Overview
  - 9.5.14.2. Financial performance
  - 9.5.14.3. Products & Services benchmarking
  - 9.5.14.4. Strategic initiatives
- 9.5.15. Veeva Systems
  - 9.5.15.1. Overview
  - 9.5.15.2. Financial performance
  - 9.5.15.3. Products & Services benchmarking
  - 9.5.15.4. Strategic initiatives
- 9.5.16. RealTime Software Solutions, LLC
  - 9.5.16.1. Overview
  - 9.5.16.2. Financial performance
  - 9.5.16.3. Products & Services benchmarking
  - 9.5.16.4. Strategic initiatives
- 9.5.17. Medidata Solution, Inc
  - 9.5.17.1. Overview
  - 9.5.17.2. Financial performance
  - 9.5.17.3. Products & Services benchmarking
  - 9.5.17.4. Strategic initiatives
- 9.5.18. ICON, plc
  - 9.5.18.1. Overview
  - 9.5.18.2. Financial performance
  - 9.5.18.3. Products & Services benchmarking
  - 9.5.18.4. Strategic initiatives
- 9.5.19. Deep 6 AI
  - 9.5.19.1. Overview
  - 9.5.19.2. Financial Performance
  - 9.5.19.3. Products & Services Benchmarking
  - 9.5.19.4. Strategic Initiatives (Acquired by Tempus on March 12, 2025)
- 9.5.20. Phesi
  - 9.5.20.1. Overview
  - 9.5.20.2. Financial Performance
  - 9.5.20.3. Products & Services Benchmarking
  - 9.5.20.4. Strategic Initiatives
- 9.5.21. Curebase
  - 9.5.21.1. Overview
  - 9.5.21.2. Financial Performance
  - 9.5.21.3. Products & Services Benchmarking
  - 9.5.21.4. Strategic Initiatives
- 9.5.22. Saama
  - 9.5.22.1. Overview
  - 9.5.22.2. Financial Performance
  - 9.5.22.3. Products & Services Benchmarking
  - 9.5.22.4. Strategic Initiatives
- 9.5.23. Suvoda LLC
  - 9.5.23.1. Overview
  - 9.5.23.2. Financial Performance
  - 9.5.23.3. Products & Services Benchmarking
  - 9.5.23.4. Strategic Initiatives (Merged with Greenphire in April 2025)
- 9.5.24. Cencora Pharmalex
  - 9.5.24.1. Overview
  - 9.5.24.2. Financial Performance
  - 9.5.24.3. Products & Services Benchmarking
  - 9.5.24.4. Strategic Initiatives (Acquired by AmerisourceBergen Corporation in January 2023)
- 9.5.25. Clinion
  - 9.5.25.1. Overview
  - 9.5.25.2. Financial Performance
  - 9.5.25.3. Products & Services Benchmarking
  - 9.5.25.4. Strategic Initiatives
- 9.5.26. Jeeva Clinical Trials Inc.
  - 9.5.26.1. Overview
  - 9.5.26.2. Financial Performance
  - 9.5.26.3. Products & Services Benchmarking
  - 9.5.26.4. Strategic Initiatives
- 9.5.27. Trial Interactive by TransPerfect
  - 9.5.27.1. Overview
  - 9.5.27.2. Financial Performance
  - 9.5.27.3. Products & Services Benchmarking
  - 9.5.27.4. Strategic Initiatives

한글목차

eClinical 솔루션 시장 개요

목차

제1장 eClinical 솔루션 시장 : 조사 방법과 범위

제2장 eClinical 솔루션 시장 : 주요 요약

제3장 eClinical 솔루션 시장 : 변수 동향과 범위

제4장 eClinical 솔루션 시장 : 제품 분석

제5장 eClinical 솔루션 시장 : 제공 형태 분석

제6장 eClinical 솔루션 시장 : 개발 단계 분석

제7장 eClinical 솔루션 시장 : 최종 용도 분석

제8장 eClinical 솔루션 시장 : 지역별 시장 분석(제품별, 제공 형태별, 개발 단계별, 최종 용도별, 2021-2033년)

제9장 eClinical 솔루션 시장 : 경쟁 구도